Skip to Main Content


Paul Stockhammer, MD, PhD

Hospital Resident

Contact Information

Paul Stockhammer, MD, PhD


Paul Stockhammer is a current physician at the Smilow Cancer Center - Yale New Haven Hospital. He completed his internal medicine residency at the Yale School of Medicine in 2023. He obtained his MD/PhD degree from Medical University of Vienna, Austria, where he studied the role of transforming growth factor-ß in pleural mesothelioma and HDAC inhibitors in lung cancer. His current research in the Politi Lab focuses on oncogene-addicted lung cancer and drug resistance, investigating the relationship between oncogenic drivers (i.e. EGFR and HER2) and co-occurring genomic alterations.

Education & Training

  • Internal Medicine Residency
    Yale School of Medicine (2023)
  • PhD
    Medical University of Vienna (2020)
  • MD
    Medical University of Vienna (2017)

Honors & Recognition

AwardAwarding OrganizationDate
Education AwardInternational Association for the Study of Lung Cancer2022
Distinguished Young Investigator Research AwardEGFR Resister Summit 2022
Travel AwardEuropean Thoracic Oncology Platform2017
Hans und Blanca Moser Stiftung AwardHans und Blanca Moser Stiftung2016

Departments & Organizations